BioCryst Pharma (BCRX) Appoints Helen Thackray, M.D., as Chief Research and Development Officer

Go back to BioCryst Pharma (BCRX) Appoints Helen Thackray, M.D., as Chief Research and Development Officer
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 12.84 +0.88 (7.36%)
Previous Close $11.96    52 Week High $10.98 
Open $12.06    52 Week Low $1.63 
Day High $13.13    P/E N/A 
Day Low $11.90    EPS $-0.68 
Volume 5,532,632